首页> 外文学位 >Synthesis and characterization of a novel hemoglobin based blood substitute.
【24h】

Synthesis and characterization of a novel hemoglobin based blood substitute.

机译:新型基于血红蛋白的血液代用品的合成与表征。

获取原文
获取原文并翻译 | 示例

摘要

The development of a blood substitute has spanned more than a full century. Many various strategies have been developed that range from completely synthetic approaches to the use of modified hemoglobin. The results of these projects have suggested that in order to avoid the side-effects observed with previously developed blood substitutes the new model must have an increased molecular weight and contain antioxidant enzymes. As a result we have developed a hemoglobin-based blood substituted with increased molecular weight and presence of antioxidant enzymes. One unique aspect of this type of a compound is its utilization of the complementary chemistry between maleimides and sulfhydryls. To our knowledge this is the first attempt to utilize this type of chemistry for the purpose of hemoglobin polymerization. The analysis of this compound has shown that a hemoglobin polymer with molecular weight range from 64 kDa to >700 kDa has been created. Addition of antioxidant enzymes into the synthesis did not alter the molecular weight distribution. However, fractional analysis of the polymer showed that the antioxidant enzymes were primarily found in the heavier part of the polymer. In addition, oxidation rates of the entire polymer with antioxidant enzymes were smaller than those of a control. These results indicate that the polymerization method we have developed produced an ordered polymer formation and that enzyme function was not compromised during the process. In this dissertation, the focus will be on describing the process of the development and synthesis of this type of a polymer which has been specifically geared to be used as a blood substitute.
机译:血液替代品的开发已经跨越了一个多世纪。从完全合成的方法到使用修饰的血红蛋白,已经开发了许多不同的策略。这些项目的结果表明,为了避免使用以前开发的血液替代品观察到的副作用,新模型必须具有增加的分子量并包含抗氧化酶。结果,我们开发了一种基于血红蛋白的血液,该血液被分子量增加和抗氧化酶的存在所取代。这种化合物的一个独特方面是它利用了马来酰亚胺和巯基之间的互补化学。据我们所知,这是为血红蛋白聚合利用这种化学方法的首次尝试。对该化合物的分析表明,已创建了分子量范围为64 kDa至> 700 kDa的血红蛋白聚合物。在合成物中添加抗氧化剂不会改变分子量分布。但是,对聚合物进行分馏分析表明,抗氧化酶主要存在于聚合物的较重部分。另外,整个聚合物被抗氧化剂酶的氧化速率比对照的氧化速率小。这些结果表明,我们开发的聚合方法可形成有序的聚合物,并且在此过程中不会损害酶的功能。在本文中,重点将放在描述这种聚合物的开发和合成过程上,该聚合物已专门用作血液替代品。

著录项

  • 作者

    Tarasov, Eugene.;

  • 作者单位

    Loyola University Chicago.;

  • 授予单位 Loyola University Chicago.;
  • 学科 Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2007
  • 页码 141 p.
  • 总页数 141
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

  • 入库时间 2022-08-17 11:39:03

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号